Bone Biologics (BBLG) Return on Assets (2013 - 2025)

Bone Biologics (BBLG) has 13 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.

• Return on Assets for Q4 2025 came in at 0.01%, up 1.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (up 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Assets improved to 0.01% in Q4 2025 per BBLG's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q1 2022 and troughed at 0.66% in Q3 2021.
• A 5-year average of 0.07% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2021 and 2023: Return on Assets soared 911 bps in 2021, then declined 2 bps in 2023.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then dropped by 11 bps to 0.01% in 2022, then slumped by 308 bps to 0.02% in 2023, then surged by 51 bps to 0.01% in 2024, then jumped by 51 bps to 0.01% in 2025.
• Business Quant data shows BBLG's Return on Assets at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.